Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00140842 · ClinicalTrials.gov registry record

Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
47
Enrollment target

NCT00140842: Completed study, sponsored by Massachusetts General Hospital.

NCT00140842 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00140842 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

This study will examine hormonal differences in ghrelin and growth hormone in obese and normal weight adolescents and their relationship to body composition and insulin resistance. The study will also investigate the effect of the macronutrient composition of a meal on postprandial ghrelin levels and whether ghrelin responses will predict the degree of hunger and caloric intake at a subsequent meal.

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2005-05
Est. Completion 2007-06

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00140842

The ClinicalTrials.gov registry entry for NCT00140842 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00140842 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00140842 about?

NCT00140842 is a clinical study titled "Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents". This study will examine hormonal differences in ghrelin and growth hormone in obese and normal weight adolescents and their relationship to body composition and insulin resistance. The study will also investigate the effect of the macronutrient composition of a meal on postprandial ghrelin levels an...

What is the current status of trial NCT00140842?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2005-05. Estimated completion is 2007-06.

Who is sponsoring clinical trial NCT00140842?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.